By Sarah N. Lynch
WASHINGTON (Reuters) - George Karavetsos, director of the Food and Drug Administration's Office of Criminal Investigations (OCI), will depart the agency to join a private law firm, according to an internal announcement seen by Reuters.
Karavetsos in January 2015 became director of the 280-unit operation, which conducts criminal probes involving food, drugs, devices, cosmetics and tobacco.
His last day will be Jan. 20, the day Donald Trump is sworn in as president.
His departure was announced Tuesday by the FDA's associate commissioner for regulatory affairs, Melinda Plaisier, and Howard Sklamberg, the deputy commissioner for global regulatory operations and policy. read more
Thank You Business Insider and Ms Lynch
FDA Hiding Reports Linking Psych Drugs To Homicide
Risperdal Suit Filed Against HHS Sec Burwell, FDA and Sec Hamburg
FDA Chief Hamburg Named In Federal Racketeering Suit JNJ, who else?
JNJ Settles Latest Risperdal Suit Before Trial